CytoMed Therapeutics Statistics
Total Valuation
GDTC has a market cap or net worth of $10.62 million. The enterprise value is $9.85 million.
| Market Cap | 10.62M |
| Enterprise Value | 9.85M |
Important Dates
| Earnings Date | n/a |
| Ex-Dividend Date | n/a |
Share Statistics
GDTC has 11.93 million shares outstanding. The number of shares has increased by 2.40% in one year.
| Current Share Class | 11.93M |
| Shares Outstanding | 11.93M |
| Shares Change (YoY) | +2.40% |
| Shares Change (QoQ) | +1.07% |
| Owned by Insiders (%) | 21.51% |
| Owned by Institutions (%) | 0.14% |
| Float | 3.52M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 17.42 |
| Forward PS | n/a |
| PB Ratio | 2.76 |
| P/TBV Ratio | 2.82 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 16.15 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 2.64, with a Debt / Equity ratio of 0.08.
| Current Ratio | 2.64 |
| Quick Ratio | 1.51 |
| Debt / Equity | 0.08 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -192.87 |
Financial Efficiency
Return on equity (ROE) is -56.17% and return on invested capital (ROIC) is -36.85%.
| Return on Equity (ROE) | -56.17% |
| Return on Assets (ROA) | -32.52% |
| Return on Invested Capital (ROIC) | -36.85% |
| Return on Capital Employed (ROCE) | -69.06% |
| Weighted Average Cost of Capital (WACC) | 4.61% |
| Revenue Per Employee | $14,517 |
| Profits Per Employee | -$64,527 |
| Employee Count | 42 |
| Asset Turnover | 0.10 |
| Inventory Turnover | 0.12 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -62.76% in the last 52 weeks. The beta is 0.07, so GDTC's price volatility has been lower than the market average.
| Beta (5Y) | 0.07 |
| 52-Week Price Change | -62.76% |
| 50-Day Moving Average | 0.90 |
| 200-Day Moving Average | 0.99 |
| Relative Strength Index (RSI) | 48.83 |
| Average Volume (20 Days) | 18,246 |
Short Selling Information
The latest short interest is 17,102, so 0.14% of the outstanding shares have been sold short.
| Short Interest | 17,102 |
| Short Previous Month | 3,620 |
| Short % of Shares Out | 0.14% |
| Short % of Float | 0.49% |
| Short Ratio (days to cover) | 1.26 |
Income Statement
In the last 12 months, GDTC had revenue of $609,727 and -$2.71 million in losses. Loss per share was -$0.23.
| Revenue | 609,727 |
| Gross Profit | 523,720 |
| Operating Income | -3.09M |
| Pretax Income | -2.74M |
| Net Income | -2.71M |
| EBITDA | -2.75M |
| EBIT | -3.09M |
| Loss Per Share | -$0.23 |
Balance Sheet
The company has $1.13 million in cash and $350,929 in debt, with a net cash position of $776,322 or $0.07 per share.
| Cash & Cash Equivalents | 1.13M |
| Total Debt | 350,929 |
| Net Cash | 776,322 |
| Net Cash Per Share | $0.07 |
| Equity (Book Value) | 4.17M |
| Book Value Per Share | 0.32 |
| Working Capital | 1.55M |
Cash Flow
In the last 12 months, operating cash flow was -$2.92 million and capital expenditures -$371,867, giving a free cash flow of -$3.29 million.
| Operating Cash Flow | -2.92M |
| Capital Expenditures | -371,867 |
| Depreciation & Amortization | 344,103 |
| Net Borrowing | 733,233 |
| Free Cash Flow | -3.29M |
| FCF Per Share | -$0.28 |
Margins
| Gross Margin | 85.89% |
| Operating Margin | -506.84% |
| Pretax Margin | -449.24% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
GDTC does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| FCF Payout Ratio | n/a |
| Buyback Yield | -2.40% |
| Shareholder Yield | -2.40% |
| Earnings Yield | -25.77% |
| FCF Yield | -31.01% |
Analyst Forecast
| Price Target | n/a |
| Price Target Difference | n/a |
| Analyst Consensus | n/a |
| Analyst Count | n/a |
| Revenue Growth Forecast (3Y) | n/a |
| EPS Growth Forecast (3Y) | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
GDTC has an Altman Z-Score of 2.81 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 2.81 |
| Piotroski F-Score | 2 |